Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Fikret Kölemen is active.

Publication


Featured researches published by Fikret Kölemen.


International Journal of Dermatology | 2005

Ultrasonographical evaluation of the Achilles’ tendon in psoriasis patients

Levent Özçakar; Alp Çetin; Fatma Inanici; Bayram Kaymak; Cansel Köse Gürer; Fikret Kölemen

Background  Psoriasis is a common dermatological disease with erythematous plaques where articular and extra articular findings (tenosynovitis and enthesitis) may well accompany. The aim of this current study was to evaluate the Achilles’ tendon of psoriasis patients with ultrasonography.


Photodermatology, Photoimmunology and Photomedicine | 2005

No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo.

Simin Ada; Sedef Sahin; Gonca Boztepe; Ayşen Karaduman; Fikret Kölemen

Background/Purpose: There is no definite cure for vitiligo; however, treatment responses with photobiological modalities are quite acceptable. Of all these, narrow‐band UVB phototherapy was proposed rather recently. Calcipotriol has been shown to have stimulating activity on melanogenesis besides immunomodulatory and anti‐inflammatory effects. This study was performed to determine whether adding topical calcipotriol to narrow‐band UVB phototherapy enhances the efficacy of treatment.


Journal of The European Academy of Dermatology and Venereology | 2006

Cutaneous mastocytosis : demographic aspects and clinical features of 55 patients

Gulsen Akoglu; Gül Erkin; Banu Cakir; Gonca Boztepe; Sedef Sahin; Ayşen Karaduman; Nilgün Atakan; T Akan; Fikret Kölemen

Background  Mastocytosis is a rare, heterogeneous group of disorder with abnormal increase of mast cells in one or more organ systems.


Journal of Cutaneous Pathology | 2007

Effect of PUVA, narrow-band UVB and cyclosporin on inflammatory cells of the psoriatic plaque

Gül Erkin; Yesim Ugur; Cansel Köse Gürer; Esin Asan; Petek Korkusuz; Sedef Şahin; Fikret Kölemen

Background:  Because antigen presenting is necessary for T‐cell activation, antigen‐presenting cells should be involved in the pathogenesis of psoriasis. In this study, our purpose was to evaluate and compare effects of PUVA, cyclosporine A and narrow‐band UVB on dendritic cells and activated lymphocytes in the psoriatic lesions.


International Journal of Dermatology | 2006

The effect of maintenance narrow-band ultraviolet B therapy on the duration of remission for psoriasis: a prospective randomized clinical trial

Gonca Boztepe; Ayşen Karaduman; Sedef Sahin; Murat Hayran; Fikret Kölemen

Background  Narrow‐band (311 nm) UVB is an effective treatment modality for moderate to severe psoriasis. The effect of maintenance narrow‐band UVB on the duration of remission is unknown.


Dermatology | 2005

A case of lupus vulgaris successfully treated with antituberculous therapy despite negative PCR and culture

Gulsen Akoglu; Ayşen Karaduman; Gonca Boztepe; Özay Özkaya; Sedef Sahin; Gül Erkin; Fikret Kölemen

A 14-year-old boy presented with a pink firm plaque with well-defined borders in the right infra-orbital skin area. On diascopy, the infiltrate exhibited a typical apple-jelly appearance. No acid-fast bacilli could be demonstrated. A polymerase chain reaction (PCR) assay did not reveal the presence of mycobacteria in a lesional biopsy sample. Culture of biopsied tissue on Loewenstein-Jensen medium was negative. Although the tuberculosis culture and PCR did not confirm tuberculosis, a diagnosis of lupus vulgaris was made considering the clinical and histopathological findings. After a 9-month antituberculous therapy, the lesion disappeared. We believe that a diagnosis of lupus vulgaris still depends more on clinical and histopathological findings than on tuberculosis culture or PCR.


Dermatology | 1981

Dermatophytic Flora of Ankara (Turkey)

Fikret Kölemen

During the period July 1, 1976, to December 31, 1978, 1,227 dermatophytes were isolated from 2,702 specimens taken from suspected cases of dermatophytosis. The dermatophytic flora was found to consist mainly of anthropophilic species. Trichophyton rubrum was by far the most frequently isolated species. Tinea capitis was caused in 36.1% of all cases by Trichophyton verrucosum, in 13.9% by Microsporum canis and Trichophyton violaceum, in 11.1% by Trichophyton schoenleinii and Trichophyton granulosum, in 5.5% by Microsporum audouinii and in 2.8% by Trichophyton sulfureum and Trichophyton tonsurans and Microsporum gypseum. Athletes foot was caused in the ratio 1:5.3:16.7 by Epidermophyton floccosum, Trichophyton interdigitale and T. rubrum.


Journal of Dermatological Treatment | 2009

Narrowband ultraviolet-B phototherapy in pityriasis lichenoides chronica

Sibel Ersoy-Evans; Asli Hapa; Gonca Boztepe; Sedef Sahin; Fikret Kölemen

Background: Current knowledge about the efficacy of narrowband UVB therapy for the treatment of pityriasis lichenoides is limited. Objective: The aim of this study was to investigate the efficacy of narrowband UVB therapy for the treatment of pityriasis lichenoides chronica (PLC). Methods: Data were retrospectively collected following a review of patient phototherapy and medical charts, and telephone interviews were performed for follow-up information. Results: The study included 25 patients (14 male, 11 female) with a mean age of 34 ± 13 years. Diagnosis was confirmed by histopathological examination in 92% (n = 23) of the patients. The median duration of the disease was 24 months (range: 2–192 months). The median number of sessions until response was 25 (8 weeks) (range: 9–77 sessions), with a median cumulative dose of 15 J/cm² (range: 2–158 J/cm²). Complete response and partial response were achieved in 48% and 44% of the patients, respectively, while 8% of the patients achieved no response. In those patients for whom follow-up data were available (n = 17), 10 (58%) relapsed within a median of 9.5 months (range: 1–44 months). Conclusions: Our results suggest that narrowband UVB is an effective and well-tolerated treatment option for PLC.


Journal of The American Academy of Dermatology | 2006

In search of an optimum dose escalation for narrowband UVB phototherapy: is it time to quit 20% increments?

Gonca Boztepe; Hande Akıncı; Sedef Şahin; Ayşen Karaduman; Sibel Ersoy Evans; Gül Erkin; Nilgün Atakan; Tülin Akan; Fikret Kölemen


/data/revues/01909622/v53i2/S0190962205009333/ | 2011

Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides

Gonca Boztepe; Sedef Sahin; Meltem Ayhan; Gül Erkin; Fikret Kölemen

Collaboration


Dive into the Fikret Kölemen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge